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Solid pseudopapillary neoplasm (SPN) is a rare tumor of the pancreas. Laparoscopic distal pancreatectomy (DP) is a feasible and safe
procedure, and successful spleen preservation rates are higher using a laparoscopic approach.We hypothesized that certain patients
with SPN would be good candidates for laparoscopic surgery; however, few surgeons have reported laparoscopic DP for SPN. We
discuss the preoperative assessment and surgical simulation for two SPN cases. A simulation was designed because we consider
that a thorough preoperative understanding of the procedure based on three-dimensional image analysis is important for successful
laparoscopic DP. We also discuss the details of the actual laparoscopic DP with or without splenic preservation that we performed
for our two SPN cases. It is critical to use appropriate instruments at appropriate points in the procedure; surgical instruments
are numerous and varied, and surgeons should maximize the use of each instrument. Finally, we discuss the key techniques and
surgical pitfalls in laparoscopic DP with or without splenic preservation. We conclude that experience alone is inadequate for
successful laparoscopic surgery.
1. Introduction
Epithelial neoplasms of uncertain differentiation, such as
solid pseudopapillary neoplasm (SPN), pancreatoblastoma,
and undifferentiated carcinoma, are rare tumors of the
pancreas. Laparoscopic surgery for pancreatic tumors is well
described [1–5] and certain patients with SPN are good
candidates for laparoscopic surgery [6, 7]. However, few
surgeons have reported laparoscopic distal pancreatectomy
(DP) for SPN [6–8]. We discuss our surgical approach
using laparoscopic DP with or without preservation of the
spleen for two patients with SPN, with the key techniques
and pitfalls. The surgical procedures were approved by our
institutional ethics committee and review board, and both
patients gave written consent for publication of the details of
their cases.
2. Case Presentation
2.1. Case 1. A 75-year-old woman underwent computed
tomography (CT) for follow-up assessment of the lung,
and a pancreatic tumor was incidentally discovered. CT
revealed a 4.0 cm tumor in the pancreatic tail. The tumor
surface was severely calcified (Figure 1(a)), and therefore
we did not attempt endoscopic ultrasound-guided fine
needle aspiration (EUS-FNA). Positron emission tomog-
raphy/CT showed no accumulation of fluorodeoxyglu-
cose in the primary tumor. Endocrine and tumor marker
levels were all within the normal ranges. Image stud-
ies including gadolinium-ethoxybenzyl-diethylenetriamine
penta-acetic acid-enhanced magnetic resonance imaging
(MRI) revealed no lymphoid or distantmetastases.The tumor
and anatomy were assessed in detail using a high-speed
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Figure 1: (a) The tumor surface was severely calcified (yellow circle). (b) Three-dimensional images revealed that the tumor involved the
SPV (yellow arrows). (c) The SPA was not involved in the tumor. (d) A total of five ports were placed. (e) and (f) The inferior ligament of the
spleen was cut (red arrow). (g) and (h) The superior ligament of the spleen was cut (red arrow). SPA, splenic artery; SPV, splenic vein.
Case Reports in Surgery 3
three-dimensional (3D) image analyzing system (Synapse
Vincent, FujifilmMedical, Tokyo, Japan).The tumor involved
the splenic vein (SPV), but not the splenic artery (SPA)
(Figures 1(b) and 1(c)). We also we ran simulations of our
laparoscopic approach using this system and discussed the
surgical procedures, preoperatively. Lymphadenectomy only
for peripancreatic lymph nodes was proposed. Under general
anesthesia, laparoscopic DP was begun with the patient in a
supine position. Five ports were placed (Figure 1(d)). After
establishing pneumoperitoneum at 10–12mmHg, a flexible
electrolaparoscope was introduced through the intraumbili-
cal port.The left gastroepiploic artery and vein were cut using
an advanced bipolar device (ENSEAL G2 Tissue Sealers,
Ethicon, Cincinnati, OH, USA), without clips. The inferior
and superior ligaments surrounding the spleen were also
cut (Figures 1(e)–1(h)). Dissection and removal of the distal
pancreas were easily and effectively performed from a dorsal
approach (Figures 2(a) and 2(b)), as in the preoperative
simulation (Figure 2(c)). Although almost all procedures for
mobilization of the pancreas can be completed using a dorsal
approach, a ventral approach also allows safe removal of
the pancreas (Figures 2(d)–2(f)). The pancreas was retracted
using umbilical tape and/or was pushed aside using the
shaft of the laparoscopic forceps (Figure 2(g)), followed by
mobilization of the distal pancreas and spleen (Figures 2(g)
and 2(h)). Based on the preoperative simulation for tumor
location and anatomical landmarks (Figure 3(a)), intraop-
erative ultrasound (Arietta, Hitachi Aloka Medical, Tokyo,
Japan) was performed to confirm the tumor location and to
determine the transection line (Figure 3(b)). The SPA was
ligated proximal to the cut line. Because we used a specific
Covidien stapler (iDrive Ultra Powered Stapling System,
Covidien, Dublin, Ireland), a preparatory surgical step for
compression was required using an atraumatic clip to ensure
safe stapling (Figures 3(c)–3(e)). For this stapling, we used
a powered endostapler preloaded with an absorbable polyg-
lycolic acid sheet (Endo GIA Reinforced Reload with Tri-
Staple Technology, black cartridge, Covidien), based on our
hypothesis that this cartridge may reinforce the pancreatic
stump. The powered stapler was used to cut the pancreas
and SPV en bloc (Figures 3(f)–3(h)). The specimen was
then extracted through the 3 cm incision in a nonpermeable
specimen pouch (Endo Catch Gold, Covidien) (Figure 4(a)).
The capsule of the pancreas remnant was checked carefully,
and a subtle injury to the capsule was seen near the staple
line (Figure 4(b)). An abdominal drain was placed near the
pancreas stump. The operative time was 3 hours and 31
minutes, and intraoperative blood loss was 30mL. On gross
section, the tumor was a solitary round mass with solid and
cystic areas and hemorrhage and was bounded by a calcified
capsule. Microscopically, surgical margins were adequate,
and lymphoidmetastasis was not detected. Although amylase
levels in the drainage fluid increased slightly during the early
postoperative period (Grade I inClavien-Dindo classification
andGradeA in the definition by International StudyGroup of
Pancreatic Surgery), the postoperative course was essentially
uneventful.
2.2. Case 2. A 29-year-old woman underwent CT for gyne-
cological examination, and a pancreatic tumor was discov-
ered incidentally. CT revealed a 2.5 cm tumor in the body of
the pancreaswith both solid and cystic areas and calcification.
Image studies (dynamic CT, MRI, and fluorodeoxyglucose-
positron emission tomography/CT) revealed no enhance-
ment in the primary tumor and no metastatic lesions. Lym-
phadenectomy only for peripancreatic lymph nodes was pro-
posed. EUS-FNAwas performed, and immunohistochemical
testing for CD56, synaptophysin, 𝛽-catenin, progesterone
receptor, CD10, galectin-3, chromogranin, and B-cell lym-
phoma/leukemia 10 was consistent with SPN. Tumor location
and invasive findings were carefully assessed using the EUS
finding and 3D image analysis (Figure 4(c)). We considered
that both the SPA and SPV were separate from this tumor,
and therefore preservation of the spleen was proposed. Gauze
was placed over the splenic hilus before opening the omental
bursa (Figure 4(d)). The reverse side of the thin membrane
of the transverse mesocolon was confirmed via a bird’s-eye
view, and the inferior splenocolic ligament was then cut
(Figure 4(e)). The anterior wall of the joint portion of the
superior mesenteric vein (SMV), SPV, and portal vein (PV)
was identified (Figure 4(f)). The 3D image revealed branches
to the SPV (Figure 4(g)), which were then carefully skele-
tonized. These venous branches were singly clipped and then
cut using ultrasonic laparoscopic coagulation shears (LCS)
(Figure 4(h)). The gastrocolic trunk (GCT) (Figure 5(a)) and
the inferior mesenteric vein (IMV) were identified next.
Countertraction was applied to the pancreas avoiding venous
injuries (Figure 5(a)) and the SPVwas skeletonized both from
the pancreatic parenchyma (Figure 5(c)) and from the dorsal
fixation by connective tissue (Figure 5(d)). The location of
the common hepatic artery (CHA) was assessed by 3D image
(Figure 4(g)) and then skeletonized at its preoperatively
planned point while avoiding injury to the vessels and the
pancreas. The nerve near the arterial sheath was useful for
grasping the CHA without causing arterial injuries (Figures
5(e) and 5(f)). The CHA was skeletonized (Figure 5(g)) and
then taped (Figure 5(h)). Venous branches from the pancreas
to the SMV and PV were assessed next. The anterior walls
of the SMV and PV were carefully and completely detached
from the pancreatic parenchyma (Figure 6(a)), and tunneling
of the pancreas was done at the level of the PV and SMV
(Figures 6(b) and 6(c)) freeing the pancreas to be taped
(Figures 6(d) and 6(e)). For subsequent surgical procedures,
the pancreas was retracted using the tape and/or was pushed
aside using the shaft of the laparoscopic forceps (Figure 6(f)).
The 3D image then revealed the dorsal pancreatic artery
(DPA) branching from the SPA near the tumor (Figure 6(g)),
detected at its preoperatively expected point (Figure 6(h)).
This arterial branch was clipped twice (Figure 7(a)) and then
cut by LCS (Figure 7(b)). Stapling was as in Case 1 and
required a prestapling compression step using the atraumatic
clip (Figures 7(c) and 7(d)). A powered stapler (iDrive
Ultra Powered Stapling System, Endo GIA with Tri-Staple
technology, black cartridge, Covidien) was then used to
cut the pancreatic parenchyma (Figure 7(e)), avoiding injury
to the vessels (Figure 7(f)). The specimen was extracted
through the 3 cm incision in a specimen pouch (Endo







































Figure 2: (a) The pancreas was retracted during a dorsal approach (green arrow). (b) During the dorsal approach, the distal pancreas
was securely mobilized by dissecting the connective tissue (red circle). (c) Removal of the pancreas by a dorsal approach was simulated
preoperatively (red arrow). (d) Removal of the pancreas by a ventral approach was also simulated preoperatively (red arrow). (e) and (f) The
pancreas was retracted (green arrow) and then a ventral approach was recommended to complete the removal of the pancreas (red arrow).
(g) and (h) The pancreas was retracted using the forceps shaft and/or tape (green arrow). Next, connective tissue and the thin membrane
surrounding the spleen were cut using a dorsal approach (red arrow). The distal pancreas and spleen were then completely removed.











































Figure 3: (a) Tumor location and anatomical landmarks were assessed preoperatively. (b) Ultrasound was performed to confirm the tumor
location and to determine the cutting line. (c) Compression using an atraumatic clip was required before proceeding further because stapling
was performed using a Covidien stapler. (d)The proximal SPA was ligated (yellow arrow) and the pancreas was compressed. (e) Compressed
parenchyma was confirmed before proceeding further (red arrows). (f), (g), and (h)The pancreas and SPVwere cut en bloc using the powered
stapler; the pancreas was retraced with tape. SPA, splenic artery; SPV, splenic vein.


















































Figure 4: (a) The specimen was extracted through a 3 cm incision in an endobag to prevent dissemination by direct contact with the tumor.
(b) The pancreatic stump and capsule were checked carefully. Subtle injury to the pancreatic membrane caused postoperative leakage of
pancreatic fluid (yellow circle). (c) The tumor location and invasive signs were assessed carefully. (d) Gauze was placed on the splenic hilus
as a landmark. The greater omentum was then cut (red arrow), and the omental bursa was opened. The left gastroepiploic vessels were cut.
(e) The splenocolic ligament along the inferior spleen was then cut (red arrow). It was critical that the reverse side of the thin membrane of
the transverse mesocolon was confirmed beforehand, via a bird’s-eye view. (f) The confluence of the SMV, SPV, and PV was confirmed. (g)
Branches from the SPVwere detected before proceeding further (yellow arrows). A suitable dissection point for CHA skeletonization was also
determined preoperatively (yellow circle). (h) Venous branches from the SPV were then skeletonized (yellow arrows).These venous branches
were singly clipped and then cut by LCS. CHA, common hepatic artery; LCS: laparoscopic coagulation sheers; PV, portal vein; SMV, superior
mesenteric vein; SPV, splenic vein.







































Figure 5: (a) The GCT was visualized. (b) The IMV was then skeletonized and preserved. (c) The SPV was skeletonized from the pancreatic
parenchyma (red arrow). (d)The SPV was separated from dorsal fixation by connective tissue (red arrow). (e) and (f)The nerve surrounding
the arterial sheath was useful to grasp the CHA without arterial injury. (g) and (h) The CHA was skeletonized and taped. CHA, common
hepatic artery; GCT, gastrocolic trunk; IMV, inferior mesenteric vein; SPV, splenic vein.
Catch II, Covidien). The staple line of the pancreatic stump
(Figure 7(g)) and the membrane of the pancreatic remnant
(Figure 7(h)) were carefully examined. The pancreatic body
and tail were then removed from the SPV (Figures 8(a)
and 8(b)) and the SPA (Figures 8(c) and 8(d)), without
any attached remnants of pancreatic parenchyma. Thus, the
spleen was successfully preserved (Figures 8(e) and 8(f)).The
local field was washed with warm saline (Figure 8(g)), and
the pancreatic stump and vessel walls were then carefully
examined (Figures 8(e) and 8(h)). An abdominal drain


















































Figure 6: (a) The anterior wall of the SMV and PV was carefully and completely separated from the pancreatic parenchyma. (b) and (c)
Tunneling of the pancreas was then performed at the level of the PV and SMV. (d) and (e)The pancreas was taped for retraction. (f) Sufficient
tension was created using the forceps shaft. (g) Three-dimensional imaging revealed that the DPA branched from the SPA near the tumor.
(h) The DPA was visualized. DPA, dorsal pancreatic artery; PV, portal vein; SMV, superior mesenteric vein; SPA, splenic artery.
was placed near the pancreatic stump. The operative time
was 5 hours and 20 minutes, and intraoperative blood
loss was 20mL. Histopathological findings revealed that the
tumor had a heterogeneous appearance with solid cellular
areas, pseudopapillary structures, hemorrhagic lesions, and
necrotic debris. Cholesterol and hyaline globule deposits
were observed, and no lymphoid metastasis was detected.
Immunohistochemical findings were consistent with SPN
and adequate surgical margins were reported. Severe leakage
of pancreatic fluid was observed early in the postoperative

















































Figure 7: (a) The DPA was clipped twice with adequate margins from the SPA (yellow arrows). (b) The DPA was then cut using LCS. (c)
Stapling was performed using the Covidien stapler with a separate and preceding compression step using an atraumatic clip. (d) Pancreatic
parenchyma was compressed beforehand (red arrows). (e) A powered stapler was used to cut the pancreatic parenchyma. (f) Lack of
involvement of vessels in the staple line was confirmed. (g) The pancreatic stump was examined. (h) The capsule of the pancreatic remnant
was checked carefully and capsular injury was identified near the staple line (yellow circles). DPA, dorsal pancreatic artery; LCS, laparoscopic
coagulation shears; SPA, splenic artery.
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period, and intravenous medications including antibiotics
were required as intentional treatments for pancreatic leakage
(Grade II in Clavien-Dindo classification and Grade B in
the definition by International Study Group of Pancreatic
Surgery).The patient was discharged on postoperative day 13.
3. Discussion
Pancreatic SPN is a rare neoplasm representing < 3% of
pancreatic cancers [9–11].Thenameof this entity dates to 1959
whenVirginia Frantz first described a “papillary-cystic tumor
of the pancreas” in the Armed Forces Institute of Pathology
band on tumors of the pancreas [12].The patient was a 2-year-
old boy who died during an attempted pancreaticoduodenec-
tomy. In 1970, Hamoudi et al. described the ultrastructural
features of the tumor, which led to its acceptance as a
separate clinicopathological entity [13]. Until its inclusion in
the World Health Organization classification of pancreatic
tumors in 1996 as “solid pseudopapillary tumor” of the pan-
creas, this condition has been described by different names
in the literature including “papillary epithelial neoplasm of
the pancreas,” “solid and cystic tumor of the pancreas,”
“adenocarcinoma of the pancreas of childhood,” “papillary-
cystic tumor,” and “solid and papillary epithelial neoplasm”
[9]. In the current World Health Organization classification
[14], SPN is defined as a low-grade malignant neoplasm of
the exocrine pancreas. The term SPN has since gained wide
acceptance and is currently themost frequently usedname for
this condition [15]. This likely reflects the increasing aware-
ness of the clinical, pathological, and radiographic features of
SPN and the uniformity of the nomenclature used for SPN in
recent years. However, the etiology and differentiation status
of SPN remain challenging and enigmatic [15]. Differential
diagnoses for rare pancreatic tumors are important, and the
immunocytochemical labeling pattern is very informative
when diagnosing SPN, neuroendocrine tumors, acinar cell
carcinomas, and pancreatoblastomas [16–19]. Usually, 𝛽-
catenin [16, 17], 𝛼1-antitrypsin [16, 18, 19], progesterone
receptor [16, 18, 19], CD10 [16, 18], CD99 [16], cytokeratin
[16, 19], synaptophysin [16, 18, 19], and chromogranin [16, 19]
are most important for immunocytochemistry.
SPN is classified as a low-grade exocrine pancreatic
malignancy [14–16]. Metastasis occurs in 5–15% of cases
[16] and lymph node metastasis occurs in 2% of cases [18].
Radiographic features have been summarized [16, 19] and
typical findings on CT are a heterogeneous mass with solid
and cystic areas, peripheral arterial enhancement of the solid
area, and central calcification [20]. On MRI, SPN displays a
heterogeneous signal in T1- and T2-weighted images, with
low intensity in noncontrast T1-weighted images and high
intensity in T2-weighted images [19]. EUS-FNA is important
for preoperative diagnosis of SPN [16, 21], although the
sensitivity and specificity of FNA are still not well defined
[20]. EUS shows a well-demarcated cystic lesion with a
solid component and calcification [16]. The first choice
of treatments for SPN is surgery [16, 18, 22–24] and the
role of chemotherapy and chemoradiation has not yet been
established [16]. Postoperative recurrences occur in 4% of
SPN patients at a mean time of 51 months [18].
Hepatobiliary pancreatic surgery represents the most
challenging area in the field of digestive surgery, and pan-
creatic surgery has been historically associated with up to
50% morbidity and 5% mortality [25, 26]. Laparoscopic
surgery is a revolutionary change in treatment [27–30].
In the field of pancreatic surgery, a porcine model of the
initial surgical concepts was described in 1994 [31], and
the first case series using these open surgical procedures
was published in 1996 [32]. Laparoscopic pancreatic surgery
was developed later [1–5, 33–39] and laparoscopic DP is
now widely accepted around the world because it does not
require anastomosis and other reconstructions [40, 41].Many
surgeons now consider laparoscopic DP a feasible and safe
procedure [34, 35, 37, 38, 42] that is associated with less
postoperative pain, faster recovery, and fewer wound-related
complications. Overall, fewer general morbidity problems
have also been documented, thus benefitting patients [34, 35,
43–47]; however, few surgeons have reported laparoscopic
DP for SPN [6–8].
Intractable bleeding from the spleen by unexpected
capsular injury is a concern. The reverse side of the thin
membrane of the transverse mesocolon should be confirmed
via a bird’s-eye view before cutting the inferior splenocolic
ligament. The mesocolon, adrenal glands, and Gerota’s fascia
are all retracted, creating the ideal surgical field for a dorsal
approach with adequate mobilization of the spleen. In almost
all cases, distal pancreas removal with skeletonization of the
SPA can be performed by simply removing connective tissues
via a dorsal approach (Figures 2(a) and 2(b)). A ventral
approach can also permit complete and safe removal of the
pancreas. To maintain the ideal surgical field, the surgical
team should be well coordinated, and forceps must not cross
during the procedures.
Laparoscopic DP is chosen mainly for patients with
benign or low-grade malignancies, and patients with SPN
are good candidates for laparoscopic DP [6, 7]. Some sur-
geons have documented laparoscopic DP with or without
splenic preservation, for SPN [6–8]. Preserving the spleen or
performing splenectomy is a topic of intense debate among
proponents of the minimally invasive approach [48–50]. The
rate of splenic conservation with laparoscopic DP is reported
as 32–84% [45, 47, 51]. The successful rate of splenic preser-
vation is higher with the laparoscopic approach [36, 45, 47];
however, splenic preservation should be carefully considered
because even subtle residual tumor tissue left from preserv-
ing splenic vessels eliminates any oncological benefit [50].
The pancreatic parenchyma should be completely removed
(Figure 8(b)) and the splenic vessels should be maintained
without parenchymal remnants (Figures 8(c) and 8(d)). The
better vision afforded by clearmagnificationwith laparoscopy
provides a higher rate of successful preservation of the
spleen [34]. In our institution, we use a full high-definition
system (Visera Elite, Olympus, Tokyo, Japan) and a flexible
laparoscope with high light intensity (10mm ENDOEYE,
Olympus), to obtain clear magnification and a high contrast
for successful laparoscopy.
The operative approach for splenic preservation should
reflect the technical considerations including tumor location
in the pancreas [50]. Splenic preservation with DP can






















































Figure 8: (a) and (b)The pancreatic body and tail were separated from the SPV. (c) and (d)The pancreatic body and tail were separated from
the SPA. (e) and (f) The spleen was successfully preserved. (g) and (h) The local field was washed thoroughly and the pancreatic stump and
vessel walls were checked carefully. SPA, splenic artery; SPV, splenic vein.
be undertaken either with preservation or with sectioning
of the splenic vessels, because blood flow to the spleen
is maintained via the short gastric vessels. This proce-
dure is called Warshaw’s technique [52]; however, splenic
infarction after laparoscopic DP with Warshaw’s technique
has been documented [53, 54]. A technical difficulty dur-
ing the preservation of splenic vessels is the division of
numerous short tributaries from the splenic vein spreading
towards the pancreas [55]; this procedure requires special
caution [55]. Appropriate use of modern technologies, such
as electrothermal bipolar vessel sealers and LCS, achieves
secure hemostasis of tributaries from the splenic vessels [34].
Additionally, although well-developed monopolar or bipolar
devices are currently available, we believe that a novel fully
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integrated device with both ultrasonically generated fric-
tional heat energy and electrically generated bipolar energy
(Thunderbeat, Olympus) is an alternative for safe cutting,
coagulation, and tissue dissection. To prepare for unexpected
bleeding, devices for secure hemostasis and vessel sealing,
such as a soft-coagulation system (VIO, Erbe, Tu¨bingen, Ger-
many), button-type electric pole with suction, self-irrigating
monopolar (IO advanced, Erbe) coagulation, and bipolar
thermofusion (BiClamp, Erbe), should be prepared preopera-
tively.Manipulation, such as rubbing a bleeding vessel using a
button-type pole with suction and a soft-coagulation system,
may also be effective for secure hemostasis.
Hand-assisted laparoscopic surgery has been used in
laparoscopic DP [56, 57], according to surgeons’ preferences
[34, 58]. In our institution, we perform pure laparoscopic DP
because hand-assisted laparoscopic surgery eliminates almost
all of the advantages of laparoscopic surgery. Single incision
laparoscopic DP has also been reported [59]. However, we do
not employ a single incision approach because of increased
risks and unfavorable limitations [60]. We perform laparo-
scopicDP in the supine position and therefore approach from
the right side after cutting the pancreas. Although a left-
sided approach may be advantageous for automatic shifting
of the distal pancreas and spleen by gravity in the right
lateral recumbent position, an approach from the right side
after cutting the pancreas provides a well-coordinated use of
forceps and scope in the supine position.
Pancreatic fistula formation after surgery remains the
primary complication following pancreatic surgery [1, 61–65].
Management of the pancreatic stump is important [1, 61–70]
and numerous important studies have been published to
aid pancreatic surgeons in this task [1, 63–67, 69–75]. There
is no difference between stapled and hand-sewn stamps
[64, 69–71]; we use a stapler in laparoscopic DP. However, the
question remains whether an orderly staple line ensures safer
closure of the pancreatic stump. We have a clear impression
that the neatness of the staple line is not associated with a
safer stump; staplers close the pancreatic stamp in a fish-
mouth shape. Pancreatic parenchyma and capsule should be
adequately included in the staple line. Studies are ongoing
to assess the hypothesis that a stapled stump is safer than
a hand-closed stump. We originally suggested that studies
should be designed as comparisons not between materials
(i.e., stapler versus hand closure), but in technical safety
(pancreatic parenchyma and membrane with or without
injury). Even subtle excess tension during countertraction
of the pancreas may result in unexpected capsular injuries.
For stability during staple firing, we use a powered stapling
device to attenuate excess countertraction asmuch as possible
(http://www.ethicon.com/healthcare-professionals/products/
staplers/endocutters/powered-echelon-flex#!overview). Sta-
plers with a rounded floor as provided by Covidien require
a separate compression step and may increase the risk of
unexpected injury to the pancreatic parenchyma and/or
capsule. In contrast, Ethicon staplers have a flat floor,
permitting an all-inclusive one-step procedure. The Echelon
Flex, Powered Endopath Stapler (Ethicon) provides safe
and secure compression with stability in one step; fewer
procedures decrease the risk of unexpected injuries.
Excess countertraction by the shaft of the forceps and/or
excess tension when retracting the tape easily injures the
pancreatic parenchyma and capsule. Staplers should hold the
pancreas as steadily as possible, with minimal countertrac-
tion on the pancreas (Figures 9(a)–9(c)) and the pancreatic
stump should be formed by adequate involution of the pan-
creatic capsule without causing injury. Optimal involution
of the parenchyma and capsule is crucial for successful
pancreatic stump formation. The pancreatic capsule should
be carefully checked after being washed (Figures 4(b) and
8(g)); even subtle injury to the pancreatic parenchyma and
capsule results in leakage of pancreatic fluid and subsequent
intraperitoneal abscess (Figures 9(a) and 9(d)). For safe
stapling, the stapler should be applied perpendicular to the
pancreas. We use a 15mm port for stapler insertion after
direct confirmation of the pancreas, although this requires
four ports to open the omental bursa (Figure 1(d)).
Although there are no definitive studies on the use of
drains after laparoscopic DP, we usually place a closed drain
at the pancreatic stump tomonitor pancreatic secretion post-
operatively. In our institution, this drain is usually removed
within four days after surgery, and dynamic CT is routinely
performed on postoperative day 7. Intraperitoneal puncture
or endoscopic drainage is performed, if needed, based on
the patient’s clinical course, laboratory data, and image
findings. Amylase and lipase levels in the drain discharge
were very informative in our two cases. Drains should be
placed automatically except in special circumstances such as
with anticipated technical difficulties related to postoperative
management of comorbid disorders.
In our institution, venous branches were singly
clipped (Figure 4(h)) and arteries were dual-clipped
(Figure 7(a)). These vessels were then cut using energy
devices (Figure 7(b)). Note that arterial branches should be
clipped at an adequate margin from the main arterial wall
because handling near the main arterial wall may result in
unexpected injury to the endothelium of the main artery
after releasing the stapler. Because intensive dissections of
the lymph nodes and arterial sheath are not required for
SPN, the nerves around the arterial sheath are useful to grasp
the arterial sheath without causing injury (Figures 5(a) and
5(b)). Specialized forceps, such as the “Mancina” forceps
(a special-order forceps made by Olympus), are useful for
grasping the nerve around the arterial sheath.
We contend that experience alone is insufficient for
achieving safety in laparoscopic surgeries [27, 28]. Preoper-
ative understanding of the planned procedure based on 3D
image analysis is critical for successful laparoscopic surgery.
In our institution, we routinely assessed the tumors and
surgical anatomy for laparoscopic DP in each case, using a
3D image analyzer (Synapse Vincent, Fujifilm Medical). This
system can detect the tumor location and depict surrounding
tissues quickly, accurately, and safely. It also enables efficient
planning of the operation settings if surgeons themselves
create the simulation images. However, this simulation and
preoperative discussion are still based on imagined sce-
narios by experienced surgeons, and the further develop-
ment of a navigational system using real-time progress is
needed.
























Figure 9: (a) Excess countertraction by the forceps and tape (yellow arrows) resulted in unexpected injury to the pancreatic parenchyma and
capsule (red circles). Excess traction on the tape was released (red arrow). (b) Excess countertraction during stapling (yellow arrows) caused
capsular injury near the staple line. Stapling should be performed as much to the dorsal side as possible to reduce excess countertraction (red
arrow). A powered stapling system attenuates excess countertraction. (c) Excess tension when withdrawing during the stapler bite (yellow
arrows) causes injury to the pancreatic parenchyma and membrane. All stapling procedures should be done at the correct position on the
pancreas (red arrows). (d) Subtle injury to the capsule (red circle) should be never missed when evaluating the safety of pancreas resection.
Current laparoscopic instruments are well developed but
each instrument should be used in the correct place and
manner. There are a variety of available stapling devices
and surgeons should follow the manufacturers’ instructions
to avoid possible malfunctions. Surgeons also must remain
updated in their knowledge of how to use these devices.Many
researchers have written systematic reviews of laparoscopic
DP, and these reviews and institutional series described
outcome parameters [76–80]. Many surgeons suggested that
laparoscopic DP is safe and reasonable [76–80], though only
few reports of laparoscopic DP for SPN were reported [6–
8]. Laparoscopic DP with or without splenic preservation is
beneficial for curative treatment of SPN if surgical procedures
are carefully considered. Preoperative understanding and
planning based on 3D image analysis are a powerful tool for
successful laparoscopic DP, and the simulation and preoper-
ative discussion are critical for oncological effectiveness and
surgical safety.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] M. A. Hilal and A. S. Takhar, “Laparoscopic left pancreatec-
tomy: current concepts,” Pancreatology, vol. 13, no. 4, pp. 443–
448, 2013.
[2] K. Takaori and N. Tanigawa, “Laparoscopic pancreatic resec-
tion: the past, present, and future,” Surgery Today, vol. 37, no.
7, pp. 535–545, 2007.
[3] A. Lebedyev, O. Zmora, J. Kuriansky et al., “Laparoscopic distal
pancreatectomy,” Surgical Endoscopy and Other Interventional
Techniques, vol. 18, no. 10, pp. 1427–1430, 2004.
[4] J. L. Dulucq, P. Wintringer, C. Stabilini, T. Feryn, J. Perissat,
and A. Mahajna, “Are major laparoscopic pancreatic resections
worthwhile? A prospective study of 32 patients in a single
institution,” Surgical Endoscopy, vol. 19, no. 8, pp. 1028–1034,
2005.
[5] T. Matsumoto, K. Shibata, M. Ohta et al., “Laparoscopic distal
pancreatectomy and open distal pancreatectomy: a nonran-
domized comparative study,” Surgical Laparoscopy, Endoscopy
and Percutaneous Techniques, vol. 18, no. 4, pp. 340–343, 2008.
[6] C.W. Kim, D. J. Han, J. Kim, Y. H. Kim, J. B. Park, and S. C. Kim,
“Solid pseudopapillary tumor of the pancreas: can malignancy
be predicted?” Surgery, vol. 149, no. 5, pp. 625–634, 2011.
[7] C. Alvise, B. Giovanni, D. Despoina et al., “Laparoscopic pan-
createctomy for solid pseudo-papillary tumors of the pancreas
14 Case Reports in Surgery
is a suitable technique; our experiencewith long-term follow-up
and review of the literature,”Annals of Surgical Oncology, vol. 18,
no. 2, pp. 352–357, 2011.
[8] Y. Cai, B. Peng, G. Mai, N. Ke, and X. Liu, “Laparoscopic
distal pancreatectomy for solid-pseudopapillary tumor of the
pancreas,” Surgical Laparoscopy, Endoscopy and Percutaneous
Techniques, vol. 25, no. 1, pp. e8–e10, 2015.
[9] N. Vassos, A. Agaimy, P. Klein, W. Hohenberger, and R. S.
Croner, “Solid-pseudopapillary neoplasm (SPN) of the pan-
creas: case series and literature review on an enigmatic entity,”
International Journal of Clinical and Experimental Pathology,
vol. 6, no. 6, pp. 1051–1059, 2013.
[10] T. Papavramidis and S. Papavramidis, “Solid pseudopapillary
tumors of the pancreas: review of 718 patients reported in
english literature,” Journal of the American College of Surgeons,
vol. 200, no. 6, pp. 965–972, 2005.
[11] L. H. Tang, H. Aydin, M. F. Brennan, and D. S. Klimstra,
“Clinically aggressive solid pseudopapillary tumors of the pan-
creas: a report of two cases with components of undifferentiated
carcinoma and a comparative clinicopathologic analysis of 34
conventional cases,”TheAmerican Journal of Surgical Pathology,
vol. 29, no. 4, pp. 512–519, 2005.
[12] V. Frantz, “Tumors of the pancreas,” inAtlas of Tumor Pathology,
C. Bumberg, Ed., pp. 32–33, US Armed Forces Institute of
Pathology, Washington, DC, USA, 1959.
[13] A. B. Hamoudi, K. Misugi, J. L. Grosfeld, and C. B. Reiner,
“Papillary epithelial neoplasm of pancreas in a child. Report of a
case with electron microscopy,” Cancer, vol. 26, no. 5, pp. 1126–
1134, 1970.
[14] G. Klo¨ppel, R. Hruban, D. Klimstra et al., “Solid-pseudo-
papillary tumor of pancreas,” in World Health Organization
Classification of Tumours of the Digestive System, F. Bosman, F.
Carneiro, R. Hruban, and N. Theise, Eds., pp. 327–330, IARC,
Lyon, France, 2010.
[15] R. C. G. Martin, D. S. Klimstra, M. F. Brennan, and K.
C. Conlon, “Solid-pseudopapillary tumor of the pancreas: a
surgical enigma?” Annals of Surgical Oncology, vol. 9, no. 1, pp.
35–40, 2002.
[16] R. Bhatnagar, M. T. Olson, E. K. Fishman, R. H. Hruban, A. M.
Lennon, and S. Z. Ali, “Solid-pseudopapillary neoplasm of the
pancreas: cytomorphologic findings and literature review,”Acta
Cytologica, vol. 58, no. 4, pp. 347–355, 2014.
[17] K. Kamei, T. Funabiki, M. Ochiai, H. Amano, M. Kasahara,
and T. Sakamoto, “Three cases of solid and cystic tumor of the
pancreas. Analysis comparing the histopathological findings
and DNA histograms,” International Journal of Pancreatology,
vol. 10, no. 3-4, pp. 269–278, 1991.
[18] J. K. Law, A. Ahmed, V. K. Singh et al., “A systematic review
of solid-pseudopapillary neoplasms: are these rare lesions?”
Pancreas, vol. 43, no. 3, pp. 331–337, 2014.
[19] A. J. Megibow, “Unusual solid pancreatic tumors,” Radiologic
Clinics of North America, vol. 50, no. 3, pp. 499–513, 2012.
[20] S. Reddy, J. L. Cameron, J. Scudiere et al., “Surgicalmanagement
of solid-pseudopapillary neoplasms of the pancreas (Franz or
Hamoudi tumors): a large single-institutional series,” Journal of
the American College of Surgeons, vol. 208, no. 5, pp. 950–957,
2009.
[21] S. Canberk, B. B. Elcin, A. Uludokumaci, N. Uygun, and F.
Gulsen, “Clear cell variant of solid pseudopapillary neoplasm of
pancreas diagnosed by fine needle aspiration: a case report and
review of the literature,” CytoJournal, vol. 10, article 26, 2013.
[22] W. Faraj, F. R. Jamali, M. Khalifeh, J. Hashash, and S. Akel,
“Solid pseudopapillary neoplasm of the pancreas in a 12-year-
old female: case report and review of the literature,” European
Journal of Pediatric Surgery, vol. 16, no. 5, pp. 358–361, 2006.
[23] X. Liu, T. M. Rauch, G. P. Siegal, and N. Jhala, “Solid-
pseudopapillary neoplasm of the pancreas: three cases with a
literature review,”Applied Immunohistochemistry andMolecular
Morphology, vol. 14, no. 4, pp. 445–453, 2006.
[24] I. Petrakis, N. Vrachassotakis, N. Kogerakis, A. Hatzidakis, O.
Zoras, and G. Chalkiadakis, “Solid pseudopapillary neoplasm
of the pancreas: report of a case after a 10-year follow-up and
review of the literature,” Pancreatology, vol. 1, no. 2, pp. 123–128,
2001.
[25] C. J. Yeo, J. L. Cameron, T. A. Sohn et al., “Six hundred fifty
consecutive pancreaticoduodenectomies in the 1990s: pathol-
ogy, complications, and outcomes,” Annals of Surgery, vol. 226,
no. 3, pp. 248–260, 1997.
[26] C. Iacono, S. Accordini, L. Bortolasi et al., “Results of pan-
creaticoduodenectomy for pancreatic cancer: extended versus
standard procedure,” World Journal of Surgery, vol. 26, no. 11,
pp. 1309–1314, 2002.
[27] S. M. Strasberg, M. Hertl, and N. J. Soper, “An analysis of the
problem of biliary injury during laparoscopic cholecystectomy,”
Journal of the American College of Surgeons, vol. 180, no. 1, pp.
101–125, 1995.
[28] M. P. Callery, “Avoiding biliary injury during laparoscopic
cholecystectomy: technical considerations,” Surgical Endoscopy
and Other Interventional Techniques, vol. 20, no. 11, pp. 1654–
1658, 2006.
[29] N. S. Abraham, J. M. Young, and M. J. Solomon, “Meta-
analysis of short-term outcomes after laparoscopic resection for
colorectal cancer,” British Journal of Surgery, vol. 91, no. 9, pp.
1111–1124, 2004.
[30] E. F. Vin˜uela, M. Gonen, M. F. Brennan, D. G. Coit, and V. E.
Strong, “Laparoscopic versus open distal gastrectomy for gastric
cancer: a meta-analysis of randomized controlled trials and
high-quality nonrandomized studies,” Annals of Surgery, vol.
255, no. 3, pp. 446–456, 2012.
[31] N. J. Soper, L. M. Brunt, D. L. Dunnegan, and T. A. Meininger,
“Laparoscopic distal pancreatectomy in the porcine model,”
Surgical Endoscopy, vol. 8, no. 1, pp. 57–61, 1994.
[32] M. Gagner, A. Pomp, andM. F. Herrera, “Early experience with
laparoscopic resections of islet cell tumors,” Surgery, vol. 120, no.
6, pp. 1051–1054, 1996.
[33] M. A. Hilal, M. Hamdan, F. Di Fabio, N. W. Pearce, and C. D.
Johnson, “Laparoscopic versus open distal pancreatectomy: a
clinical and cost-effectiveness study,” Surgical Endoscopy and
Other Interventional Techniques, vol. 26, no. 6, pp. 1670–1674,
2012.
[34] M. Iacobone, M. Citton, and D. Nitti, “Laparoscopic distal pan-
createctomy: up-to-date and literature review,”World Journal of
Gastroenterology, vol. 18, no. 38, pp. 5329–5337, 2012.
[35] D. Borja-Cacho,W. B. Al-Refaie, S.M. Vickers, T.M. Tuttle, and
E. H. Jensen, “Laparoscopic distal pancreatectomy,” Journal of
the American College of Surgeons, vol. 209, no. 6, pp. 758–765,
2009.
[36] A. C. Jusoh and B. J. Ammori, “Laparoscopic versus open distal
pancreatectomy: a systematic review of comparative studies,”
Surgical Endoscopy and Other Interventional Techniques, vol. 26,
no. 4, pp. 904–913, 2012.
[37] R. Venkat, B. H. Edil, R. D. Schulick, A. O. Lidor, M. A. Makary,
and C. L. Wolfgang, “Laparoscopic distal pancreatectomy is
Case Reports in Surgery 15
associated with significantly less overall morbidity compared
to the open technique: a systematic review and meta-analysis,”
Annals of Surgery, vol. 255, no. 6, pp. 1048–1059, 2012.
[38] S. Pericleous, N. Middleton, S. C. McKay, K. A. Bowers,
and R. R. Hutchins, “Systematic review and meta-analysis of
case-matched studies comparing open and laparoscopic distal
pancreatectomy: is it a safe procedure?” Pancreas, vol. 41, no. 7,
pp. 993–1000, 2012.
[39] P. J. Kneuertz, S. H. Patel, C. K. Chu et al., “Laparoscopic distal
pancreatectomy: trends and lessons learned through an 11-year
experience,” Journal of theAmericanCollege of Surgeons, vol. 215,
no. 2, pp. 167–176, 2012.
[40] A. Sa Cunha, A. Rault, C. Beau, C. Laurent, D. Collet, and B.
Masson, “A single-institution prospective study of laparoscopic
pancreatic resection,” Archives of Surgery, vol. 143, no. 3, pp.
289–295, 2008.
[41] T. Mori, N. Abe, M. Sugiyama, and Y. Atomi, “Laparo-
scopic pancreatic surgery,” Journal of Hepato-Biliary-Pancreatic
Surgery, vol. 12, no. 6, pp. 451–455, 2005.
[42] N. B.Merchant, A. A. Parikh, andD. A. Kooby, “Should all distal
pancreatectomies be performed laparoscopically?” Advances in
Surgery, vol. 43, no. 1, pp. 283–300, 2009.
[43] M. S. Baker, D. J. Bentrem, M. B. Ujiki, S. Stocker, and M.
S. Talamonti, “A prospective single institution comparison
of peri-operative outcomes for laparoscopic and open distal
pancreatectomy,” Surgery, vol. 146, no. 4, pp. 635–645, 2009.
[44] G. R. Nigri, A. S. Rosman, N. Petrucciani et al., “Metaanal-
ysis of trials comparing minimally invasive and open distal
pancreatectomies,” Surgical Endoscopy and Other Interventional
Techniques, vol. 25, no. 5, pp. 1642–1651, 2011.
[45] S. C. Kim, K. T. Park, J. W. Hwang et al., “Comparative analysis
of clinical outcomes for laparoscopic distal pancreatic resection
and open distal pancreatic resection at a single institution,”
Surgical Endoscopy, vol. 22, no. 10, pp. 2261–2268, 2008.
[46] B. W. Eom, J.-Y. Jang, S. E. Lee, H.-S. Han, Y.-S. Yoon, and S.-W.
Kim, “Clinical outcomes compared between laparoscopic and
open distal pancreatectomy,” Surgical Endoscopy, vol. 22, no. 5,
pp. 1334–1338, 2008.
[47] S. S. Mehta, G. Doumane, T. Mura, D. Nocca, and J.-M. Fabre,
“Laparoscopic versus open distal pancreatectomy: a single-
institution case-control study,” Surgical Endoscopy and Other
Interventional Techniques, vol. 26, no. 2, pp. 402–407, 2012.
[48] A. Sasaki, H. Nitta, J. Nakajima, T. Obuchi, S. Baba, and G.
Wakabayashi, “Laparoscopic spleen-preserving distal pancrea-
tectomy with conservation of the splenic artery and vein: report
of three cases,” Surgery Today, vol. 38, no. 10, pp. 955–958, 2008.
[49] G.-Y. Lv, G.-Y. Wang, C. Jiang et al., “Laparoscopic spleen-
preserving distal pancreatectomy with or without splenic ves-
sel conservation: a retrospective study of 20 cases,” Hepato-
Gastroenterology, vol. 60, no. 127, pp. 1785–1788, 2013.
[50] D. J. Worhunsky, Y. Zak, M. M. Dua, G. A. Poultsides, J.
A. Norton, and B. C. Visser, “Laparoscopic spleen-preserving
distal pancreatectomy: the technique must suit the lesion,”
Journal of Gastrointestinal Surgery, vol. 18, no. 8, pp. 1445–1451,
2014.
[51] L. Ferna´ndez-Cruz, L. Blanco, R. Cosa, and H. Rendo´n, “Is
laparoscopic resection adequate in patients with neuroen-
docrine pancreatic tumors?” World Journal of Surgery, vol. 32,
no. 5, pp. 904–917, 2008.
[52] A. L. Warshaw, “Conservation of the spleen with distal pancre-
atectomy,” Archives of Surgery, vol. 123, no. 5, pp. 550–553, 1988.
[53] A. L.Warshaw, “Distal pancreatectomy with preservation of the
spleen,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 17, no.
6, pp. 808–812, 2010.
[54] S. Shimizu, M. Tanaka, H. Konomi, T. Tamura, K. Mizumoto,
and K. Yamaguchi, “Spleen-preserving laparoscopic distal pan-
createctomy after division of the splenic vessels,” Journal of
Laparoendoscopic and Advanced Surgical Techniques Part A, vol.
14, no. 3, pp. 173–177, 2004.
[55] A. Pietrabissa, C. Moretto, U. Boggi, G. Di Candio, and F.
Mosca, “Laparoscopic distal pancreatomy: are we ready for a
standardized technique?” Seminars in Laparoscopic Surgery, vol.
11, no. 3, pp. 179–183, 2004.
[56] M. Gagner and P. Gentileschi, “Hand-assisted laparoscopic
pancreatic resection,” Seminars in Laparoscopic Surgery, vol. 8,
no. 2, pp. 114–125, 2001.
[57] M. D’Angelica, C. Are, W. Jarnagin et al., “Initial experience
with hand-assisted laparoscopic distal pancreatectomy,” Surgi-
cal Endoscopy and Other Interventional Techniques, vol. 20, no.
1, pp. 142–148, 2006.
[58] B. U. Laxa, A. M. Carbonell II, W. S. Cobb et al., “Laparoscopic
and hand-assisted distal pancreatectomy,” American Surgeon,
vol. 74, no. 6, pp. 481–486, 2008.
[59] T. Kuroki, T. Adachi, T. Okamoto, and T. Kanematsu,
“Single-incision laparoscopic distal pancreatectomy,” Hepato-
Gastroenterology, vol. 58, no. 107-108, pp. 1022–1024, 2011.
[60] T. Hori, N. Okada, M. Nakauchi et al., “Hematogenous umbil-
ical metastasis from colon cancer treated by palliative single-
incision laparoscopic surgery,”World Journal of Gastrointestinal
Surgery, vol. 5, no. 10, pp. 272–277, 2013.
[61] B. J. Ammori and G. D. Ayiomamitis, “Laparoscopic pancreati-
coduodenectomy and distal pancreatectomy: a UK experience
and a systematic review of the literature,” Surgical Endoscopy,
vol. 25, no. 7, pp. 2084–2099, 2011.
[62] I. Makino, H. Kitagawa, H. Nakagawara et al., “The man-
agement of a remnant pancreatic stump for preventing the
development of postoperative pancreatic fistulas after distal
pancreatectomy: current evidence and our strategy,” Surgery
Today, vol. 43, no. 6, pp. 595–602, 2013.
[63] G. Farkas, L. Leindler, J. Marton, G. La´za´r, and G. Farkas
Jr., “PolysorbR (an absorbable lactomer) staples, a safe closure
technique for distal pancreatic resection,” World Journal of
Gastroenterology, vol. 20, no. 45, pp. 17185–17189, 2014.
[64] R. E. Jimenez and W. G. Hawkins, “Emerging strategies to
prevent the development of pancreatic fistula after distal pan-
createctomy,” Surgery, vol. 152, no. 3, pp. S64–S70, 2012.
[65] T. I. Carter, Z. V. Fong, T. Hyslop et al., “A dual-institution
randomized controlled trial of remnant closure after distal
pancreatectomy: does the addition of a falciform patch and
fibrin glue improve outcomes?” Journal of Gastrointestinal
Surgery, vol. 17, no. 1, pp. 102–109, 2013.
[66] T. Hackert, J. Werner, and M. W. Bu¨chler, “Postoperative
pancreatic fistula,” Surgeon, vol. 9, no. 4, pp. 211–217, 2011.
[67] C. Wilson, S. Robinson, J. French, and S. White, “Strategies to
reduce pancreatic stump complications after open or laparo-
scopic distal pancreatectomy,” Surgical Laparoscopy, Endoscopy
and Percutaneous Techniques, vol. 24, no. 2, pp. 109–117, 2014.
[68] M. Montorsi, A. Zerbi, C. Bassi et al., “Efficacy of an absorbable
fibrin sealant patch (TachoSil) after distal pancreatectomy: a
multicenter, randomized, controlled trial,” Annals of Surgery,
vol. 256, no. 5, pp. 853–860, 2012.
16 Case Reports in Surgery
[69] H. P. Knaebel,M. K. Diener,M.N.Wente,M.W. Bu¨chler, andC.
M. Seiler, “Systematic review andmeta-analysis of technique for
closure of the pancreatic remnant after distal pancreatectomy,”
British Journal of Surgery, vol. 92, no. 5, pp. 539–546, 2005.
[70] W. Zhou, R. Lv, X. Wang, Y. Mou, X. Cai, and I. Herr,
“Stapler vs suture closure of pancreatic remnant after distal
pancreatectomy: a meta-analysis,” The American Journal of
Surgery, vol. 200, no. 4, pp. 529–536, 2010.
[71] M. K. Diener, C. M. Seiler, I. Rossion et al., “Efficacy of
stapler versus hand-sewn closure after distal pancreatectomy
(DISPACT): a randomised, controlled multicentre trial,” The
Lancet, vol. 377, no. 9776, pp. 1514–1522, 2011.
[72] M. M. Bilimoria, J. N. Cormier, Y. Mun, J. E. Lee, D. B. Evans,
and P. W. T. Pisters, “Pancreatic leak after left pancreatectomy
is reduced following main pancreatic duct ligation,” British
Journal of Surgery, vol. 90, no. 2, pp. 190–196, 2003.
[73] M. Wagner, B. Gloor, M. Ambu¨hl et al., “Roux-en-Y drainage
of the pancreatic stump decreases pancreatic fistula after distal
pancreatic resection,” Journal of Gastrointestinal Surgery, vol. 11,
no. 3, pp. 303–308, 2007.
[74] A. Chikamoto, D. Hashimoto, Y. Ikuta et al., “Effects of the
closing speed of stapler jaws on bovine pancreases,” Surgical
Endoscopy, vol. 28, no. 1, pp. 336–340, 2014.
[75] D. B. Evans and P. W. T. Pisters, “Novel applications of endo
GIA linear staplers during pancreaticoduodenectomy and total
pancreatectomy,”The American Journal of Surgery, vol. 185, no.
6, pp. 606–607, 2003.
[76] L. M. Postlewait and D. A. Kooby, “Laparoscopic distal pancre-
atectomy for adenocarcinoma: safe and reasonable?” Journal of
Gastrointestinal Oncology, vol. 6, no. 4, pp. 406–417, 2015.
[77] T. de Rooij, R. Sitarz, O. R. Busch, M. G. Besselink, and M. Abu
Hilal, “Technical aspects of laparoscopic distal pancreatectomy
for benign and malignant disease: review of the literature,”
Gastroenterology Research and Practice, vol. 2015, Article ID
472906, 9 pages, 2015.
[78] J. Barrie and B. J. Ammori, “Minimally invasive distal pancre-
atectomy: a single-center analysis of outcome with experience
and systematic review of the literature,” Surgical Laparoscopy,
Endoscopy & Percutaneous Techniques, vol. 25, no. 4, pp. 297–
302, 2015.
[79] I. Damoli, G. Butturini, M. Ramera et al., “Minimally invasive
pancreatic surgery—a review,” Wideochirurgia i Inne Techniki
Maloinwazyjne, vol. 10, no. 2, pp. 141–149, 2015.
[80] P. Sperlongano, E. Esposito, A. Esposito et al., “Laparoscopic
pancreatectomy: did the indications change? A review from
literature,” International Journal of Surgery, vol. 21, supplement
1, pp. S22–S25, 2015.



















































 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
